ANAVEX LIFE SCIENCES CORP. Additional Paid in Capital, Common Stock
ANAVEX LIFE SCIENCES CORP. (AVXL) had Additional Paid in Capital, Common Stock of $498.00 million as of 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-28
- 2026-06-30: Additional Paid in Capital, Common Stock $498.00M.
- 2026-03-31: Additional Paid in Capital, Common Stock $515.08M.
- 2025-12-31: Additional Paid in Capital, Common Stock $514.65M.
- 2025-09-30: Additional Paid in Capital, Common Stock $477.23M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $498.00M 10-Q · filed 2026-08-28 | |
| 2026-03-31 | $515.08M 10-Q · filed 2026-08-28 | |
| 2025-12-31 | $514.65M 10-Q · filed 2026-02-09 | |
| 2025-09-30 | $477.23M 10-K/A · filed 2026-08-28 | |
| 2025-06-30 | $463.49M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $459.05M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $459.01M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $456.25M 10-K/A · filed 2026-08-28 | |
| 2024-06-30 | $454.24M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $447.35M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $437.18M 10-Q · filed 2024-02-07 | |
| 2023-09-30 | $434.84M 10-K · filed 2024-12-23 | |
| 2023-06-30 | $429.60M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $416.73M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $393.58M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $387.98M 10-K · filed 2023-11-27 | $387.98M 10-K · filed 2022-11-28 |
| 2022-06-30 | $381.93M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $371.44M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $354.76M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $348.33M 10-K · filed 2022-11-28 | |
| 2021-06-30 | $342.94M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $251.43M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $213.77M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $186.85M 10-K · filed 2021-11-24 | |
| 2020-06-30 | $178.33M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $171.96M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $165.89M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $153.63M 10-K · filed 2020-12-28 | |
| 2019-06-30 | $148.93M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $138.70M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $133.44M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $129.38M 10-K · filed 2019-12-16 | |
| 2018-06-30 | $126.68M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $122.72M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $121.04M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $115.69M 10-K · filed 2019-01-25 | |
| 2017-06-30 | $109.73M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $104.16M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $100.30M 10-Q · filed 2017-02-07 | |
| 2016-09-30 | $84.29M 10-K · filed 2017-12-11 | |
| 2016-06-30 | $79.14M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $78.91M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $76.13M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $74.06M 10-K · filed 2016-12-14 | |
| 2014-09-30 | $50.71M 10-K · filed 2015-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |